Evidence map›Paper›PMID 35350997›Full record

ArticleBMC genomic data2022

Whole exome sequencing of pediatric leukemia reveals a novel InDel within FLT-3 gene in AML patient from Mizo tribal population, Northeast India.

Andrew Vanlallawma, Doris Lallawmzuali, Jeremy L Pautu, Vinod Scaria, Sridhar Sivasubbu, Nachimuthu Senthil Kumar

Open access · goldAbstract read
In one paragraph

Article in BMC genomic data, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Andrew VanlallawmaDepartment of Biotechnology, Mizoram University, Aizawl, Mizoram, 796004, India.
Doris LallawmzualiDepartment of Pathology, Mizoram State Cancer Institute, Zemabawk, Aizawl, Mizoram, 796017, India.
Jeremy L PautuDepartment of Medical Oncology, Mizoram State Cancer Institute, Zemabawk, Aizawl, Mizoram, 796017, India.
Vinod ScariaCSIR - Institute of Genomics and Integrative Biology, South Campus, Mathura Road, New Delhi, 110025, India.
Sridhar SivasubbuCSIR - Institute of Genomics and Integrative Biology, South Campus, Mathura Road, New Delhi, 110025, India.
Nachimuthu Senthil KumarDepartment of Biotechnology, Mizoram University, Aizawl, Mizoram, 796004, India. nskmzu@gmail.com.
Cancer Institute (WIA) · INInstitute of Genomics and Integrative Biology · INMizoram University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLeukemia is the most common type of cancer in pediatrics. Genomic mutations contribute towards the molecular mechanism of disease progression and also helps in diagnosis and prognosis. This is the first scientific mutational exploration in whole exome of pediatric leukemia patients from a cancer prone endogamous Mizo tribal population, Northeast India.

resultThree non-synonymous exonic variants in NOTCH1 (p.V1699E), MUTYH (p.G143E) and PTPN11 (p.S502P) were found to be pathogenic. A novel in-frame insertion-deletion within the juxtamembrane domain of FLT3 (p.Tyr589_Tyr591delinsTrpAlaGlyAsp) was also observed.

conclusionThese unique variants could have a potential mutational significance and these could be candidate genes in elucidating the possibility of predisposition to cancers within the population. This study merits further investigation for its role in diagnosis and prognosis and also suggests the need for population wide screening to identify unique mutations that might play a key role towards precision medicine.

Indexed as

fms-Like Tyrosine Kinase 3Leukemia, Myeloid, AcuteChildExome SequencingHumansINDEL MutationIndiaMutationFLT3 protein, humanfms-Like Tyrosine Kinase 3Exome sequencingFLT3MizoramNon-synonymousPediatric leukemiaPTPN11

Identifiers

PMID35350997
PMCPMC8961913
OpenAlexW4220852524

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.